Clinical testing is underway for a potentially groundbreaking new treatment for cystic fibrosis. Pioneered by scientists at Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign and the Carver College of Medicine at the University of Iowa in partnership with the spin-out biotechnology company, cystetic Medicines, this promising inhalable molecular prosthetic is intended to improve lung function in people with CF who cannot benefit from current therapies.
Neutrophil reprogramming promotes tumor growth in certain cancers
A new research study led by A*STAR.Singapore Immunology Network (A*STAR.SIgN) has found that neutrophils-;one of the most abundant white blood cells in our body-;change drastically
February 23, 2024